CC BY 4.0 · Arq Neuropsiquiatr 2024; 82(S 02): S53-S176
DOI: 10.1055/s-0045-1806984
ID: 564
Area: Neurogenetics
Presentation method: Presentation Poster

Microcephaly, epilepsy, sleep disorder and movement disorder in the heterozygote variant in the NCAPH gene: case report

Amanda Barbiero Grando
1   Centro Universitário Fundação Assis Gurgacz, Cascavel PR, Brazil.
,
Marta Regina Clivati
1   Centro Universitário Fundação Assis Gurgacz, Cascavel PR, Brazil.
,
Isadora Debona Oliveira
1   Centro Universitário Fundação Assis Gurgacz, Cascavel PR, Brazil.
› Institutsangaben
 

    *Correspondence: abarbierogrando@gmail.com.

    Abstract

    Case Presentation: Patient M.C.R.Z.N, female, two years old, firstborn, medical history of maternal infection, caused by Covid-19, on the tenth gestational week. The patient was born at 36 weeks with microcephaly and throughout the neonatal screening infectious causes of microcephaly were discarded. The patient evolved with spastic cerebral palsy, neurodevelopment disorder, epilepsy and a movement disorder. Due to the proton magnetic resonance spectroscopy, it was observed microcephaly, without anomalous calcification, severe atrophy of the corpus callosum, existing septum pellucidum, discreet ventriculomegaly classified as atrophic, bilateral incomplete hippocampal inversion, mild cortical atrophy, mild and severe decrease of the volume of deep white matter. And the proton MR spectroscopy indicates the presence of an anomalous peak of lactate in the cerebral parenchyma and a reduction of the peak of Naa. It developed with epileptic spasms, which were treated with vigabatrin. The scenario was associated with a movement disorder exhibiting dystonia crises and persistent sleep disorder. Dystonia manifested a partial recovery with the administration of baclofen, after being exchanged for gabapentin, with a positive response. To the sleep disorder it was administered periciazine, levomepromazine, melatonin and amitriptyline and cannabidiol, however the insomnia persists. Regarding epilepsy, its spasms were controlled with vigabatrin and in its development there were focus crises, which were controlled with oxcarbazepine, with great irritability as a result of the previous administration of levetiracetam. Along the investigation it was proven through the sequencing of the complete exome a variant in heterozygosis in the NCAPH gene, classified as a variant of uncertain meaning.

    Discussion: The heterogeneous variant found is located in the NCAPH gene, in the chromosome region 2q112. This gene codifies proteins which take part in the stages of the cell cycle, resulting in a troubled line of the cleavage plan of the neural progenitors. Pathogenic variants in this gene are associated with primary microcephaly classified as type 23, autosomal recessive.

    Final Comments: The case report is important due to the lack of literature about this genetic disorder, distinguishing this as the first Brazilian case which was diagnosed and reported.


    #

    Publikationsverlauf

    Artikel online veröffentlicht:
    12. Mai 2025

    © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

    Thieme Revinter Publicações Ltda.
    Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil